UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 368

Sortiert nach

Phase I Study of Quizartinib Administered Daily to Patients With Relapsed or Refractory Acute Myeloid Leukemia Irrespective of FMS-Like Tyrosine Kinase 3–Internal Tandem Duplication Status

Journal of clinical oncology, 2013-10, Vol.31 (29), p.3681-3687

2013

Link zum Volltext

Verfügbarkeit prüfen

New prognostic markers in acute myeloid leukemia: perspective from the clinic

Hematology, 2010, Vol.2010 (1), p.47-55

Foran, James M

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical Presentation, Diagnosis, and Prognosis of Myelodysplastic Syndromes

The American journal of medicine, 2012-07, Vol.125 (7), p.S6-S13

2012

Link zum Volltext

Verfügbarkeit prüfen

A prospective study of the relationship between illness perception, depression, anxiety, and quality of life in hematopoietic stem cell transplant patients

Cancer medicine (Malden, MA), 2024-02, Vol.13 (3), p.e6906-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Can venetoclax-based therapy replace 7+3 induction in fit older adults with AML?

Best practice & research. Clinical haematology, 2021-12, Vol.34 (4), p.101335-101335, Article 101335

Foran, James M.

2021

Link zum Volltext

Verfügbarkeit prüfen

Loneliness, immunological recovery patterns, and health-related quality of life (HRQOL) outcomes in patients receiving hematopoietic stem cell transplantation

BMC Psychology, 2024-01, Vol.12 (1), p.40-40, Article 40

2024

Link zum Volltext

Verfügbarkeit prüfen

Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome

Blood cancer journal (New York), 2023-04, Vol.13 (1), p.49-49, Article 49

2023

Link zum Volltext

Verfügbarkeit prüfen

U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity

Blood cancer journal (New York), 2023-09, Vol.13 (1), p.149-149, Article 149

2023

Link zum Volltext

Verfügbarkeit prüfen

Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation

Blood cancer journal (New York), 2021-03, Vol.11 (3), p.49-49, Article 49

2021

Link zum Volltext

Verfügbarkeit prüfen

Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events

Blood cancer journal (New York), 2023-08, Vol.13 (1), p.122-122, Article 122

2023

Link zum Volltext

Verfügbarkeit prüfen

Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases

Blood cancer journal (New York), 2022-07, Vol.12 (7), p.103-103, Article 103

2022

Link zum Volltext

Verfügbarkeit prüfen

Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma

Blood cancer journal (New York), 2022-06, Vol.12 (6), p.87-87, Article 87

2022

Link zum Volltext

Verfügbarkeit prüfen

Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Blood cancer journal (New York), 2023-03, Vol.13 (1), p.35-35, Article 35

2023

Link zum Volltext

Verfügbarkeit prüfen

Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes

Cancer medicine (Malden, MA), 2018-02, Vol.7 (2), p.499-507

2018

Link zum Volltext

Verfügbarkeit prüfen

An Innovative Phase I Clinical Study Demonstrates Inhibition of FLT3 Phosphorylation by SU11248 in Acute Myeloid Leukemia Patients

Clinical cancer research, 2003-11, Vol.9 (15), p.5465-5476

2003

Link zum Volltext

Verfügbarkeit prüfen

Nonimmunoglobulin Crystal-Storing Histiocytosis (CSH): Case Report and Literature Review

Case reports in hematology, 2020-10, Vol.2020, p.1-4

2020

Link zum Volltext

Verfügbarkeit prüfen

Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML

Blood, 2018-03, Vol.131 (13), p.1415-1424

2018

Link zum Volltext

Verfügbarkeit prüfen

Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH-based algorithm distinguishes prognostic groups and outcomes

Blood cancer journal (New York), 2021-09, Vol.11 (9), p.156-156, Article 156

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

Clinical cancer research, 2021-04, Vol.27 (8), p.2190-2199

2021

Link zum Volltext

Verfügbarkeit prüfen

Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy

Journal of clinical oncology, 2022-05, Vol.40 (15), p.1671-1680

2022

Link zum Volltext

Verfügbarkeit prüfen

Do cytogenetics affect the post-remission strategy for older patients with AML in CR1?

Best practice & research. Clinical haematology, 2017-12, Vol.30 (4), p.306-311

Foran, James M.

2017

Link zum Volltext

Verfügbarkeit prüfen

Primary peritoneal myeloid sarcoma in association with CBFB/MYH11 fusion

Leukemia research reports, 2021-01, Vol.15, p.100238, Article 100238

2021

Link zum Volltext

Verfügbarkeit prüfen

Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study

Journal of clinical oncology, 2015-01, Vol.33 (3), p.251-257

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

Leukemia, 2021-12, Vol.35 (12), p.3542-3550

2021

Link zum Volltext

Verfügbarkeit prüfen

Venetoclax plus hypomethylating agent in blast‐phase myeloproliferative neoplasm: preliminary experience with 12 patients

British journal of haematology, 2020-12, Vol.191 (5), p.e120-e124

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 368

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(342)
Mit Volltextzugriff
(346)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(128)
Life Sciences & Biomedicine
(124)
Humans
(116)
Hematology
(77)
Male
(57)
Female
(52)
Aged
(51)
Oncology
(48)
Middle Aged
(46)
Adult
(45)
Aged, 80 And Over
(27)
Biological And Medical Sciences
(26)
Acute Myeloid Leukemia
(25)
Leukemia, Myeloid, Acute - Drug Therapy
(23)
Leukemia, Myeloid, Acute - Genetics
(23)
Medical Sciences
(22)
Leukemia
(21)
Mutation
(21)
Treatment Outcome
(20)
Patients
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Phase I Study of Quizartinib Administered Daily to Patients With Relapsed or Refractory Acute Myeloid Leukemia Irrespective of FMS-Like Tyrosine Kinase 3–Internal Tandem Duplication Status

New prognostic markers in acute myeloid leukemia: perspective from the clinic

Clinical Presentation, Diagnosis, and Prognosis of Myelodysplastic Syndromes

A prospective study of the relationship between illness perception, depression, anxiety, and quality of life in hematopoietic stem cell transplant patients

Can venetoclax-based therapy replace 7+3 induction in fit older adults with AML?

Loneliness, immunological recovery patterns, and health-related quality of life (HRQOL) outcomes in patients receiving hematopoietic stem cell transplantation

Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome

U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity

Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation

Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events

Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases

Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma

Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes

An Innovative Phase I Clinical Study Demonstrates Inhibition of FLT3 Phosphorylation by SU11248 in Acute Myeloid Leukemia Patients

Nonimmunoglobulin Crystal-Storing Histiocytosis (CSH): Case Report and Literature Review

Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML

Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH-based algorithm distinguishes prognostic groups and outcomes

Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy

Do cytogenetics affect the post-remission strategy for older patients with AML in CR1?

Primary peritoneal myeloid sarcoma in association with CBFB/MYH11 fusion

Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

Venetoclax plus hypomethylating agent in blast‐phase myeloproliferative neoplasm: preliminary experience with 12 patients

Suchergebnisse filtern